Role of non-classical MHC class I molecules in cancer immunosuppression

Lentiviral Vectors: A Versatile Tool to Fight Cancer

(2013) P.U. Emeagi et al.   CURRENT MOLECULAR MEDICINE

Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding

(2013) Roberta Rizzo et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

The immunosuppressive molecule HLA-G and its clinical implications

(2012) Ãlvaro González et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Full-length HLA-G1 and truncated HLA-G3 differentially increase HLA-E surface localization

(2012) Takele Teklemariam et al.   HUMAN IMMUNOLOGY

Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma

(2012) X. Zhang et al.   INTERNATIONAL JOURNAL OF CANCER

HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells

(2012) Fabian Wolpert et al.   JOURNAL OF NEUROIMMUNOLOGY

HLA-E expression in cervical adenocarcinomas: association with improved long-term survival

(2012) Vivian M Spaans et al.   Journal of Translational Medicine

Clinical Significance of the HLA-E and CD94/NKG2 Interaction

(2011) Milena Iwaszko et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17

(2011) S. Agaugue et al.   BLOOD

HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression

(2011) Céline Bossard et al.   INTERNATIONAL JOURNAL OF CANCER

High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis

(2011) Maria Benevolo et al.   Journal of Translational Medicine

HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer

(2011) Aifen Lin et al.   LUNG CANCER

A Comprehensive Study of Polymorphic Sites along the HLA-G Gene: Implication for Gene Regulation and Evolution

(2011) E. C. Castelli et al.   MOLECULAR BIOLOGY AND EVOLUTION

Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: Possible implications

(2011) Leos Kren et al.   PATHOLOGY RESEARCH AND PRACTICE

Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer

(2011) Mathilde Allard et al.   PLoS One

HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes

(2011) M. Gooden et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HLA-F is a surface marker on activated lymphocytes

(2010) Ni Lee et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

HLA-E–restricted regulatory CD8+ T cells are involved in development and control of human autoimmune type 1 diabetes

(2010) Hong Jiang et al.   JOURNAL OF CLINICAL INVESTIGATION

Expression of Soluble HLA-G Identifies Favorable Outcomes in Liver Transplant Recipients

(2010) Valeriya Zarkhin et al.   TRANSPLANTATION

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Induction of Both Membrane‐Bound and Soluble HLA‐G Expression in Active Human Cytomegalovirus Infection

(2009) Wei‐Hua Yan et al.   JOURNAL OF INFECTIOUS DISEASES

Beyond the increasing complexity of the immunomodulatory HLA-G molecule

(2008) E. D. Carosella et al.   BLOOD

Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway

(2008) S. Liang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection

(2007) J.C.O. Crispim et al.   TRANSPLANT IMMUNOLOGY